Conference Overview

As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes to monitoring its usage. In recent years, pharmacovigilance has gained significant attention and importance due to the growing complexity of drug therapies, the emergence of new medicines, and the increased scrutiny of regulatory agencies. This has led to a greater emphasis on monitoring the safety profiles of pharmaceutical products throughout their lifecycle, from pre-marketing clinical trials to post-marketing surveillance.


The need for effective pharmacovigilance systems becomes even more crucial as the global population continues to expand, resulting in an increased consumption of medications. Adverse drug reactions (ADRs) can have severe consequences, leading to hospitalizations, prolonged treatments, and in some cases, even fatalities. Therefore, it is imperative to enhance our understanding of ADRs, identify potential risks, and implement appropriate risk mitigation strategies. To efficiently address these challenges, collaboration between international regulatory bodies, healthcare providers, and patients is essential. With a strong focus on patient safety as well as public health and by creating an interconnected network of experts from around the world who are dedicated to advancing our understanding of drug safety and pharmacovigilance, we can create a robust system.

This conference will serve as a knowledge-sharing and networking platform, providing a unique opportunity for researchers, pharmacists, healthcare professionals, industry representatives, and regulatory authorities to come together and discuss the latest trends, challenges, and advancements in pharmacovigilance. By sharing experiences and best practices, we aim to enhance global drug safety and improve patient outcomes. Throughout the conference, we will delve into various topics such as signal detection and management, adverse event reporting and analysis, risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance.


Our esteemed panel of speakers, comprising leading experts from academia, industry, and regulatory agencies, will present their research findings, share case studies, and engage in thought-provoking discussions. The conference will also feature interactive networking opportunities, fostering collaboration and enabling the exchange of ideas.


We are delighted to welcome you to the Pharmacovigilance World 2024, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.

Conference Streams Include



Global PV & Methodologies

Data management & Analytics in PV

PV Automation, AI & Machine Learning

Safety Signals & Management

Pharmacovigilance Regulations


Patient Centric Drug Safety


Quality &

Pharmacovigilance Outsourcing

Medical Devices Safety

Adverse Drug Reactions




  • Pharmacovigilance and globalization
  • Pharmacovigilance in a pandemic world
  • Women and child health care medicines and pharmacovigilance
  • Patient-centric approaches in PV
  • Pharmacovigilance legislation and regulations
  • Harmonization and pharmacovigilance
  • Advanced therapeutic techniques and pharmacovigilance
  • Pharmacovigilance and data management and eudravigilance
  • Post-marketing surveillance in pharmacovigilance
  • PV regulations and challenges
  • Benefit-risk management strategies
  • Risk management and minimization
  • Risk Evaluation and Mitigation
  • Adverse drug reactions reporting
  • Signal detection and post authorization safety
  • Good Pharmacovigilance Practices
  • Innovative approaches to drug safety
  • Strategies to improve PV
  • Real World Evidence in PV
  • Big data and AI in pharmacovigilance
  • Pharmacovigilance Workflows with AI & Automation
  • Other emerging technologies in PV





C-level, Presidents, Senior/Global Vice Presidents, Directors, Directors, Heads & Managers, Scientific Advisors, Consultants and professionals who work for pharmaceutical, biotechnology & devices industries, CROs and service providers involved in Pharmacovigilance and Drug safety.


  • Pharmacovigilance
  • Safety & Risk management
  • Drug safety
  • PV Compliance
  • Safety Surveillance
  • Medical Affairs
  • Regulatory Affairs
  • Inspection and Audit
  • Pharmacoepidemiology
  • Post-market studies
  • Medical product safety assessment
  • Drug Research & Development
  • Clinical Pharmacology
  • Medical information
  • Contract outsourcing service providers
  • Health outcomes
  • Sales and Marketing





pharmaceutical companies



There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to

Become a Speaker

Wednesday - 11th September 2024

  • 08:15
  • Registration & Refreshments

    Kick off your conference experience by checking in at our registration desk. Collect your event materials and enjoy a selection of refreshments. It's the perfect time to mingle with fellow attendees and set the tone for an engaging and informative event

  • 08:50
  • Welcome Address & Chairperson’s opening remarks

    Begin your conference journey with a warm welcome from our esteemed Chairperson

Strengthening Pharmacovigilance Systems and Practices

  • 09:00
  • Improving Drug Safety Through Adverse Event Detection with Natural Language Processing (NLP) and Generative AI

    • The transformative impact of Natural Language Processing (NLP) on the efficiency and accuracy of adverse event detection in pharmacovigilance.
    • How NLP techniques can convert unstructured textual data from sources like medical records, social media, and patient narratives into actionable insights for drug safety monitoring.
    • The challenges, such as data quality and privacy concerns, as well as the opportunities presented by NLP in improving drug safety, including early signal detection and more precise risk assessment.

    Jordi Casanellas

    Jordi Casanellas Head of Language AI

  • 09:25
  • Failure Modes in Pharmacovigilance Systems

    Andrew Cooper

    Andrew Cooper Director, Pharmacovigilance Quality Assurance

  • 09:50
  • Practical considerations for creating a proactive safety and pharmacovigilance plan

    For sponsorship opportunities please contact: or call +44 (0) 207 096 0786

    • Implementing comprehensive and proactive monitoring mechanisms to detect adverse drug reactions and safety signals early, utilizing both traditional and innovative data sourceshurdles in forming a network that includes pharmaceutical companies, healthcare providers, and regulatory bodies for improved drug safety monitoring
    • Ensuring that pharmacovigilance teams are well-trained and equipped with the necessary skills and knowledge to effectively identify and manage potential safety issues
    • Regularly reviewing and updating the pharmacovigilance plan to incorporate new insights, technological advancements, and regulatory changes, ensuring that the plan remains effective and relevant

  • 10:15
  • The Intersection of Digital Health and Pharmacovigilance for Enhanced Drug Safety

    Daniela Bernardini

    Daniela Bernardini Country Patient Safety Head
    Novartis Italia

  • 10:40
  • Business Card Exchange with Morning Coffee/Tea & Discussion

    Network over morning coffee or tea, exchanging business cards or using our app's QR code scanner for easy contact sharing. A prime moment for engaging discussions and new connections



  • 11:00
  • Booked for Linguamatics

  • 11:30
  • Creating and Implementing a Global Signal Management Tool

    • Internal and regulatory challenges in managing Pfizer's extensive safety signals portfolio and the innovative system/process implemented to address them.
    • Workflow for signal collection, validation, and communication of validated/evaluated signals and risks to health authorities, including report generation for inspections and PSUR contributions.
    • Advantages and considerations of developing an in-house Signal Management system

    David Jones

    David Jones Director - Pharmacovigilance Process and Systems Specialist

  • 11:55
  • Leveraging Expertise at PV Affiliates: Enhancing Decision Making through Cross-Functional Collaboration

    Begum Benli Peker

    Begum Benli Peker Head of Patient Safety Netherlands & EU Hub
    Bristol Myers Squibb

  • 12:20
  • Impact of the Harmonisation of PV Regulations in the Post Covid-19 Pandemic Era.

    Kinga Faulkner

    Kinga Faulkner Drug Safety Lead

  • 12:45
  • Luncheon & Networking - Explore, Engage with Your Peers, and Connect at Our Exhibitor Booths

    Enjoy a luncheon while networking with peers and exploring exhibitor booths. This is an ideal time to engage with industry leaders, delve into innovative solutions, and forge valuable connections in a collaborative atmosphere.



  • 13:25
  • Elevating Drug Safety: The Crucial Role of Quality Case Processing in Pharmacovigilance

    Laura Arce Mora

    Laura Arce Mora Senior Country Safety Lead Central America and Caribbean

  • 13:50
  • New challenges for pharmacovigilance: how become a strategic function for business

    Andrea Oliva

    Andrea Oliva Head of pharmacovigilance, Italy

  • 14:15
  • Panel Discussion - Integrated Drug Safety Surveillance Systems: Fostering Collaboration for Enhanced Pharmacovigilance

    • Assessing the benefits and hurdles in forming a network that includes pharmaceutical companies, healthcare providers, and regulatory bodies for improved drug safety monitoring
    • Discussing strategies for standardizing data collection, reporting, and analysis across various organizations to ensure consistent and reliable pharmacovigilance
    • Investigating how AI, blockchain, and big data are transforming ADR detection and analysis, increasing the efficiency and precision of pharmacovigilance
    • Emphasizing the need for effective communication and collaboration among patients, healthcare providers, and regulatory bodies to establish a trust-based pharmacovigilance system
    • Detailing best practices and essential factors for successful collaborative pharmacovigilance, with a focus on regulatory compliance, data privacy, and cross-sector cooperation

    Nadia Hussain

    Nadia Hussain PV Operations Manager (Deputy ASR)

    Jordi Casanellas

    Jordi Casanellas Head of Language AI

  • 14:45
  • Diverse Approaches to Communication in Pharmacovigilance: Examining Risk Minimization Measures Across Different Countries

    Nick Nikberg

    Nick Nikberg Senior Patient Safety Specialist

  • 15:10
  • Recharge with Tea or Coffee While Networking

    Refresh with a tea or coffee break, using this time to continue networking. It's a perfect opportunity to discuss ideas, share experiences, and connect with fellow attendees in a relaxed setting.



  • 15:30
  • Auditing Pharmacovigilance Automation

    Sophie Keddie

    Sophie Keddie Compliance Senior Manager

  • 15:55
  • Revolutionizing Signal Detection: Cutting-Edge Techniques and Strategic Breakthroughs

    • Delving into the shortcomings and limitations of conventional signal detection techniques, setting the stage for the need for innovation.
    • Highlighting the latest advancements and novel strategies recently introduced in the field, showcasing their ingenuity and potential.
    • Examining the tangible benefits and improvements these innovative strategies have brought to signal detection studies, demonstrating their effectiveness and value.

    Zina Sadeq

    Zina Sadeq Director, Regional PV & Alliance Management
    Amicus Therapeutics

  • 16:20
  • Mastering Compliance and Best Practices in Drug Safety Monitoring

    • Effective strategies for establishing and maintaining comprehensive adverse event reporting mechanisms, crucial for timely detection and response to drug safety issues.
    • The challenges and strategies for staying compliant with the diverse and evolving pharmacovigilance regulations across different countries and regions.
    • The importance of ongoing training, education, and process evaluation within organizations to ensure adherence to best practices in pharmacovigilance and continual enhancement of drug safety monitoring.

    Marianne Banoub

    Marianne Banoub Regional Head, Pharmacovigialcne and Quality Assurance
    NewBridge Pharmaceuticals

  • 16:45
  • Elevating Pharmacovigilance Systems: Achieving Excellence in Audit and Inspection Readiness

    Valentina Mancini

    Valentina Mancini Senior Director Pharmacovigilance, QPPV
    Shionogi Europe

  • 17:10
  • Case Study on Emerging safety issue management

    Arun Ravindran

    Arun Ravindran Patient Safety Physician - Immunology

  • 17:35
  • Interactive Breakout Round Table Discussion

    All the participants will have a great opportunity to discuss and explore a selection of most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.

    • Table 1 - Leveraging Telehealth Innovations for Pharmacovigilance: Exploring how telemedicine platforms and digital health records can enhance adverse event reporting and patient safety monitoring.
    • Table 2 - Advanced Analytics in Signal Detection: Delving into how machine learning and predictive analytics are transforming signal detection in pharmacovigilance.
    • Table 3 - Optimizing Drug Safety with Real-Time Data: Discussing the integration of real-time health data from wearables and mobile apps into pharmacovigilance systems.
    • Table 4 - Global Pharmacovigilance Regulations: Challenges and Convergence: Navigating the differing pharmacovigilance regulations across countries and the push towards regulatory harmonization.
    • Table 5 - Patient Engagement and Empowerment in Pharmacovigilance: Evaluating strategies to improve patient involvement in the reporting of adverse events and drug safety monitoring.
    • Table 6 - Enhancing Pharmacovigilance with Natural Language Processing (NLP): Examining how NLP technologies can improve the extraction and analysis of data from unstructured sources like social media and health forums.

  • 18:05
  • Chair Person's Closing remarks

    End the conference with the Chairperson's closing remarks, summarizing key insights and leaving attendees with final thoughts to inspire ongoing engagement and action.

  • 18:15
  • Networking Drinks Session - Unwind with Evening Drinks and Engaging Conversations

    Wrap up the day with evening drinks and lively conversations. A relaxed setting to network, share insights from the day, and enjoy the company of fellow attendees.

Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.

register now


Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to


Hilton London Kensington,
179-199 Holland Park Avenue,
London W11 4UL,
United Kingdom

We make every effort to secure the very best hotel for our attendees with amazing event spaces, so that we’re able to guarantee our attendees the highest quality service and comfort.


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now